Abstract
Clinical experience has demonstrated that gliomas of the brain are relatively resistant to conventional irradiation (teletherapy) (Bloom and Walsh 1975; Burger et al. 1979; Leibel and Sheline 1987). Thus, the dose-effect curve for tumor control and the tissue damage curve obtained in many clinical situations turn out to be almost identical. This has led to various attempts to increase the therapeutic spectrum of radiotherapy. Apart from the stereotaxic focusing of radiation with linear accelerators, brachytherapy has been receiving a considerable amount of attention again in the past few years (Bernstein and Gutin 1981; Gutin and Leibel 1985; Ostertag 1986). The dose rates used for interstitial radiation vary from very high dose rates for different afterloading techniques to very low dose rates for permanent implants with low-energy emitters such as iodine 125. The dosimetry calculations for interstitial irradiation have been based largely on clinical experience (Anderson et al. 1981; Hilaris 1975). To devitalize a tumor with high local radiation doses no longer poses as serious a problem as the damage done to the tumor-free tissue. This damage is not so much the harm inflicted by direct radiation but rather that caused by secondary chronic vasogenic edema. In order to obtain confirmed biological data as a foundation on which to base the clinical dosimetry, we studied the effects of doses delivered through γ-emitters with different energy and dose rates.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson LL, Hsin MK, Ing-Yuan D (1981) Clinical dosimetry with 125-I. In: George FW (ed) Modern interstitial and intracavitary radiation cancer management. Masson, New York
Bernstein M, Gutin PH (1981) Interstitial irradiation of brain tumors: a review. Neurosurgery 6: 741–750
Bloom HJG, Walsh LS (1975) Tumors of the central nervous system. In: Blood HJG, Lemerle J, Neidhardt MK (eds), Cancer in children. Clinical management. Springer, Berlin Heidelberg New York
Burger PC, Mahaley MS, Dudka L, Vogel FS (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas. Cancer 44: 1256–1272
Caveness WF (1980) Experimental observations: delayed necrosis in normal monkey brain. In: Gilbert HA, Kagan AR (eds) Radiation damage to the nervous system. Raven, New York, pp 1–38
Fike JR, Cann CE, Phillips TL, Bernstein M, Gutin PH, Turowsky K, Weaver KA, Davis RL, Higgins RJ, Da-Silva V (1985) Radiation brain damage induced by interstitial 125-I sources: a canine model evaluated by quantitative computed tomography. Neurosurgery 16: 530–537
Groothuis DR, Vriesendorp F, Mikhael M, Blasberg RG, Patlak C (1984) Quantitative measurement of brain tumor capillary permeability by CT: application in canine gliomas and implications for use in patients. Neurology [Suppl 1] (NY) 34: 185–186
Groothuis DR, Wright DC, Ostertag CB (1987) The effect of I-125 interstitial radiotherapy on blood-brain barrier function in normal canine brain. J Neurosurg 67: 895–902
Gutin PH, Leibel SA (1985) Stereotactic interstitial irradiation of malignant brain tumors. Neurol Clin 3: 883–893
Hall EJ (1978) Radiobiology for the radiologist. Harper and Row, Hagerstown
Hilaris BS (1975) Handbook of interstitial brachytherapy. Publishing Sciences Group, Acton
Janzer RC, Kleihues P, Ostertag CB (1986) Early and late effects on the normal dog brain of permanent interstitial Iridium-192 irradiation. Acta Neuropathol (Berl) 70: 91–102
Krishnaswamy V (1978) Dose distribution around an 125-I seed source in tissue. Radiology 126: 489–491
Leibel SA, Sheline GE (1987) Radiation therapy for neoplasms of the brain. J Neurosurg 66: 1–22
Ostertag CB (1986) Stereotactic brachytherapy of brain tumors. In: Gerosa MA (ed) Brain tumors biopathology and therapy. Pergamon, Oxford, pp 175–183
Ostertag CB, Hossmann KA, v.d. Kerckhoff W (1982) Radiation effects of iridium-192 implants in the cat brain. Nucl Med 21: 99–104
Ostertag CB, Weigel K, Warnke P, Lombeck G, Kleihues P (1983) Sequential morphological changes in the dog brain after interstitial Iodine-125 irradiation. Neurosurgery 13: 523–528
Ostertag CB, Warnke P, Kleihues P, Bigner D (1984) Iodine-125 interstitial irradiation of virally induced dog brain tumors. Neurol Res 6: 176–180
Sondhaus CA (1981) I-125: physical properties, photon dosimetry and effectiveness. In: George FW (ed) Modern interstitial and intracavitary radiation cancer management. Masson, New York
Turowsky K, Fike JR, Cann CE, Higgins RJ, Davis RL, Gutin PH, Phillips TL, Weaver KA (1986) Normal brain iodine-125 radiation damage: effect of dose and irradiated volume in a canine model. Radiology 158: 833–838
Warnke PC, Groothuis DR, Ostertag CB (1988) Quantitative Bestimmung der bidirektionalen kapillären Permeabilität im Verlauf bei interstitieller Bestrahlung. In: Bamberg M, Sack H (eds) Therapie primärer Hirntumoren. Zuckschwerdt, Mûnich, pp 63–66
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ostertag, C.B. (1991). Experimental Dose Effects After Permanent and Temporary Interstitial Irradiation of the Brain. In: Sauer, R. (eds) Interventional Radiation Therapy. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84163-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-84163-7_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84165-1
Online ISBN: 978-3-642-84163-7
eBook Packages: Springer Book Archive